Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Association Between Physical Fitness and Cognitive Function in Multiple Sclerosis: Does Disability Status Matter?
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
Nature plus nurture: the triggering of multiple sclerosis.
Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.
Disease mechanisms in MS: RNA profiling uncovers two distinct subsets of patients with multiple sclerosis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Childhood transverse myelitis and its mimics.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Risk of relapse phenotype recurrence in multiple sclerosis.
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
Long-term benefits of induction therapy in NMO: a case report.
Early accurate diagnosis crucial in multiple sclerosis.

Pages